The protease inhibitor lopinavir, boosted with ritonavir, as treatment for COVID-19: a rapid review.,Antiviral Therapy

当前位置： X-MOL 学术 › Antivir. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

The protease inhibitor lopinavir, boosted with ritonavir, as treatment for COVID-19: a rapid review.
Antiviral Therapy ( IF 1.3 ) Pub Date : 2021-03-11 , DOI: 10.3851/imp3385
Jienchi Dorward _{1,

2} , Oghenekome Gbinigie ₁ , Ting Cai ₁ , Nia W Roberts ₃ , Nigel Garrett _{2,

4} , Gail Hayward ₁ , Christopher C Butler ₁

Affiliation

The HIV protease inhibitor lopinavir, boosted with ritonavir, has been used off-label to treat COVID-19. We aimed to synthesise the clinical evidence for lopinavir/ritonavir as a treatment for COVID-19.

中文翻译：